Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Smith

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Antiviral Research|February 24, 2024
An in vivo duck hepatitis B virus model recapitulates key aspects of nucleic acid polymer treatment outcomes in chronic hepatitis B patientsYannick Debing, Hannah Vanrusselt, Lars Degrauwe, et al.
NPJ Breast Cancer|November 21, 2024
Multi-institutional report of trastuzumab deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastasesVaseem M Khatri, Mariella A Mestres-Villanueva, Sreenija Yarlagadda, et al.
Bioorganic & Medicinal Chemistry Letters|April 5, 2012
Discovery of 4'-azido-2'-deoxy-2'-C-methyl cytidine and prodrugs thereof: a potent inhibitor of Hepatitis C virus replicationMagnus Nilsson, Genadiy Kalayanov, Anna Winqvist, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2009
Non-nucleoside inhibitors of HCV polymerase NS5B. Part 4: structure-based design, synthesis, and biological evaluation of benzo[d]isothiazole-1,1-dioxidesJavier de Vicente, Robert T Hendricks, David B Smith, et al.
Journal of Medicinal Chemistry|November 22, 2024
The Discovery and Preclinical Profile of ALG-000184, a Prodrug of the Potent Hepatitis B Virus Capsid Assembly Modulator ALG-001075Sandrine Vendeville, Franck Amblard, Leda Bassit, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2009
Non-nucleoside inhibitors of HCV polymerase NS5B. Part 3: synthesis and optimization studies of benzothiazine-substituted tetramic acidsJavier de Vicente, Robert T Hendricks, David B Smith, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2009
Non-nucleoside inhibitors of HCV polymerase NS5B. Part 2: Synthesis and structure-activity relationships of benzothiazine-substituted quinolinedionesJavier de Vicente, Robert T Hendricks, David B Smith, et al.
Journal of Medicinal Chemistry|June 30, 2025
Discovery and Preclinical Profile of ALG-097558, a Pan-Coronavirus 3CLpro InhibitorDorothée Bardiot, David C McGowan, Kusum Gupta, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Antiviral Research|February 24, 2024
An in vivo duck hepatitis B virus model recapitulates key aspects of nucleic acid polymer treatment outcomes in chronic hepatitis B patientsYannick Debing, Hannah Vanrusselt, Lars Degrauwe, et al.
NPJ Breast Cancer|November 21, 2024
Multi-institutional report of trastuzumab deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastasesVaseem M Khatri, Mariella A Mestres-Villanueva, Sreenija Yarlagadda, et al.
Bioorganic & Medicinal Chemistry Letters|April 5, 2012
Discovery of 4'-azido-2'-deoxy-2'-C-methyl cytidine and prodrugs thereof: a potent inhibitor of Hepatitis C virus replicationMagnus Nilsson, Genadiy Kalayanov, Anna Winqvist, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2009
Non-nucleoside inhibitors of HCV polymerase NS5B. Part 4: structure-based design, synthesis, and biological evaluation of benzo[d]isothiazole-1,1-dioxidesJavier de Vicente, Robert T Hendricks, David B Smith, et al.
Journal of Medicinal Chemistry|November 22, 2024
The Discovery and Preclinical Profile of ALG-000184, a Prodrug of the Potent Hepatitis B Virus Capsid Assembly Modulator ALG-001075Sandrine Vendeville, Franck Amblard, Leda Bassit, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2009
Non-nucleoside inhibitors of HCV polymerase NS5B. Part 3: synthesis and optimization studies of benzothiazine-substituted tetramic acidsJavier de Vicente, Robert T Hendricks, David B Smith, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2009
Non-nucleoside inhibitors of HCV polymerase NS5B. Part 2: Synthesis and structure-activity relationships of benzothiazine-substituted quinolinedionesJavier de Vicente, Robert T Hendricks, David B Smith, et al.
Journal of Medicinal Chemistry|June 30, 2025
Discovery and Preclinical Profile of ALG-097558, a Pan-Coronavirus 3CLpro InhibitorDorothée Bardiot, David C McGowan, Kusum Gupta, et al.
Pageof 6